TriangleHonokiol (NCT06566443)
Honokiol trial for Early-Stage Resectable Non-Small Cell Lung Cancer (NCT06566443). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for early stage lung cancer, in adults scheduled for curative surgery.
The idea: test honokiol, a dietary supplement, before the operation. Patients take it for two weeks ahead of surgery. Spanish speaking patients are included, with translation provided. The study enrolls only stage one lung cancers smaller than four centimeters.
This phase 1 study plans about 15 patients and looks for the maximum tolerated dose of honokiol. At Houston Methodist Neal Cancer Center in Texas, Jun Zhang leads it.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.